HRP20000108A2 - Tetrahydro gamma-carbolines - Google Patents

Tetrahydro gamma-carbolines

Info

Publication number
HRP20000108A2
HRP20000108A2 HR20000108A HRP20000108A HRP20000108A2 HR P20000108 A2 HRP20000108 A2 HR P20000108A2 HR 20000108 A HR20000108 A HR 20000108A HR P20000108 A HRP20000108 A HR P20000108A HR P20000108 A2 HRP20000108 A2 HR P20000108A2
Authority
HR
Croatia
Prior art keywords
optionally substituted
6alkyl
aryl
carbolines
tetrahydro
Prior art date
Application number
HR20000108A
Other languages
English (en)
Inventor
Ludo Edmund Josephine Kennis
Josephus Carolus Mertens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HRP20000108A2 publication Critical patent/HRP20000108A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HR20000108A 1997-09-08 1998-09-01 Tetrahydro gamma-carbolines HRP20000108A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202761A EP0905136A1 (en) 1997-09-08 1997-09-08 Tetrahydro gamma-carbolines
PCT/EP1998/005710 WO1999012926A1 (en) 1997-09-08 1998-09-01 Tetrahydro gamma-carbolines

Publications (1)

Publication Number Publication Date
HRP20000108A2 true HRP20000108A2 (en) 2000-12-31

Family

ID=8228715

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000108A HRP20000108A2 (en) 1997-09-08 1998-09-01 Tetrahydro gamma-carbolines

Country Status (27)

Country Link
US (2) US6303614B1 (cs)
EP (2) EP0905136A1 (cs)
JP (1) JP2001515899A (cs)
KR (1) KR100603896B1 (cs)
CN (1) CN1110496C (cs)
AT (1) ATE243209T1 (cs)
AU (1) AU752410B2 (cs)
BR (1) BR9811769A (cs)
CA (1) CA2301807A1 (cs)
CZ (1) CZ297220B6 (cs)
DE (1) DE69815700T2 (cs)
EE (1) EE04496B1 (cs)
ES (1) ES2202902T3 (cs)
HR (1) HRP20000108A2 (cs)
HU (1) HUP0003577A3 (cs)
ID (1) ID23954A (cs)
IL (1) IL134894A (cs)
MY (1) MY129176A (cs)
NO (1) NO315236B1 (cs)
NZ (1) NZ503096A (cs)
PL (1) PL191863B1 (cs)
RU (1) RU2208614C2 (cs)
SK (1) SK285594B6 (cs)
TR (1) TR200000616T2 (cs)
TW (1) TW531539B (cs)
WO (1) WO1999012926A1 (cs)
ZA (1) ZA988161B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG146683A1 (en) 2003-09-17 2008-10-30 Janssen Pharmaceutica Nv Fused heterocyclic compounds as serotonin receptor modulators
UA85563C2 (ru) * 2003-09-17 2009-02-10 Янссен Фармацевтика Н.В. Конденсированные гетероциклические соединения
EP1944306A1 (en) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as serotonin receptor modulators
JP4816453B2 (ja) * 2004-04-12 2011-11-16 大正製薬株式会社 環状アミン化合物
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
FR2885905A1 (fr) * 2005-05-23 2006-11-24 Trophos Sa Nouveaux composes chimiques et leurs utilisations comme medicament
WO2007009485A1 (en) * 2005-07-22 2007-01-25 Pharma C S.A. Substituted 8-phenoxy-y-carboline derivatives with 5ht1 activity
WO2007058580A1 (en) * 2005-11-15 2007-05-24 Astrazeneca Ab Novel 2-aminopyrimidinone derivatives and their use
US20080083807A1 (en) * 2006-10-06 2008-04-10 Beardsley John W Surgical instrument including a locking assembly
AU2008302751A1 (en) * 2007-09-20 2009-03-26 D2E, Llc Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use
EP2236511A4 (en) 2007-12-21 2011-04-13 Alla Chem Llc LIGANDS OF ALPHA ADRENOCEPTORS AND OF DOPAMINE, HISTAMIN, IMIDAZOLIN AND SEROTONIN RECEPTORS AND THEIR APPLICATION THEREOF
RU2374245C1 (ru) 2008-08-22 2009-11-27 Андрей Александрович Иващенко Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство
CN105399674B (zh) 2015-12-31 2017-02-15 青岛清原化合物有限公司 吡唑类化合物或其盐、制备方法、除草剂组合物及用途
CN106631941B (zh) * 2016-12-30 2018-09-28 青岛瀚生生物科技股份有限公司 一种2-甲基-3氯苯基甲硫醚的制备方法
GB201704325D0 (en) * 2017-03-17 2017-05-03 Argonaut Therapeutics Ltd Compounds
CN110698474B (zh) * 2019-11-14 2021-11-02 福州大学 一种α位取代四氢-γ-咔啉类化合物及其制备方法和应用
US20230339949A1 (en) * 2020-10-09 2023-10-26 Shujing Biopharma Co., Ltd HETEROCYCLIC SUBSTITUTED FUSED y-CARBOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND USE THEREOF

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3410286C2 (de) * 1984-03-21 1986-01-23 Fresenius AG, 6380 Bad Homburg Verfahren zur Trennung von Blut sowie Vorrichtung zur Durchführung des Verfahrens
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
RU2067980C1 (ru) * 1992-06-30 1996-10-20 Глэксо Груп Лимитед Производные лактама и фармацевтическая композиция, являющаяся антагонистом 5-окситраптамина /5-нт/ на 5- нт3 -рецепторах или их физиологически приемлемые соли и соловаты
ES2204932T3 (es) * 1994-09-12 2004-05-01 Eli Lilly And Company Limited Moduladores serotonergicos.

Also Published As

Publication number Publication date
AU752410B2 (en) 2002-09-19
DE69815700D1 (en) 2003-07-24
PL191863B1 (pl) 2006-07-31
PL339143A1 (en) 2000-12-04
TW531539B (en) 2003-05-11
RU2208614C2 (ru) 2003-07-20
CZ2000726A3 (cs) 2000-07-12
KR100603896B1 (ko) 2006-07-25
IL134894A (en) 2005-03-20
CA2301807A1 (en) 1999-03-18
EE04496B1 (et) 2005-06-15
CN1269800A (zh) 2000-10-11
EP0905136A1 (en) 1999-03-31
ES2202902T3 (es) 2004-04-01
NO20000737D0 (no) 2000-02-14
SK2992000A3 (en) 2001-03-12
DE69815700T2 (de) 2004-04-29
NO20000737L (no) 2000-05-08
CN1110496C (zh) 2003-06-04
JP2001515899A (ja) 2001-09-25
AU9742198A (en) 1999-03-29
TR200000616T2 (tr) 2000-07-21
WO1999012926A1 (en) 1999-03-18
US20020103209A1 (en) 2002-08-01
CZ297220B6 (cs) 2006-10-11
ID23954A (id) 2000-06-08
EP1015451A1 (en) 2000-07-05
SK285594B6 (sk) 2007-04-05
BR9811769A (pt) 2000-08-29
US6506768B2 (en) 2003-01-14
ZA988161B (en) 2000-03-22
HK1029107A1 (en) 2001-03-23
KR20010022391A (ko) 2001-03-15
US6303614B1 (en) 2001-10-16
NO315236B1 (no) 2003-08-04
EE200000059A (et) 2000-10-16
ATE243209T1 (de) 2003-07-15
HUP0003577A3 (en) 2003-05-28
NZ503096A (en) 2001-11-30
MY129176A (en) 2007-03-30
HUP0003577A2 (hu) 2001-09-28
EP1015451B1 (en) 2003-06-18
IL134894A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
AU617918B2 (en) 2-aminopyrimidinone derivatives
DE69815700D1 (en) Tetrahydro gamma-carboline
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
HU896723D0 (en) Process for preparation of guanidine-derivatives and insecticid compositions comprising these compounds as active ingredient
NL300298I1 (nl) Nieuwe 3-piperidinyl-1,2-benzisoxazolen
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
MXPA03011244A (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6.
HU9401974D0 (en) New intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
EP0430201A3 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
EP0604354A3 (en) Antidepressant and anti-Parkinson's disease compounds.
MY125562A (en) Hexahydro-pyrido (4,3-b) indole derivatives as antipsychotic drugs
NZ225022A (en) Substituted ergoline derivatives and pharmaceutical compositions
AU5595490A (en) Antispasmodic agents
GR3017435T3 (en) Antihypertensive 3-piperidinyl-indazole derivatives.
BG105521A (en) Benzisoxazoles and phenons as alpha2-antagonists
TW275629B (cs)

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20060807

Year of fee payment: 9

OBST Application withdrawn